Skip to main content

Advertisement

SpringerLink
Log in

Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program

  • Research article
  • Published:
Journal of Diabetes & Metabolic Disorders Aims and scope Submit manuscript

Abstract

Background

This study proposed to compare the prevalence and risk factors for sarcopenia by EGWSOP-1 and EWGSOP-2 diagnostic criteria in Iran.

Methods

This cross-sectional study was conducted based on the data collected during the Bushehr Elderly Health (BEH) Program, stage II. Sarcopenia was defined as 3 definitions: EWGSOP-1(with Iranian cut off), EWGSOP-2(with Iranian cut off), EWGSOP-2(with European cut off) definition. We evaluated the age-standardized prevalence of sarcopenia in both genders. Regression analysis was used to show the associations in the adjusted models.

Results

Among 2426 participants, age-standardized prevalence of sarcopenia, and severe sarcopenia by EWGSOP-1 were 19.7%, and 12.9%, in men and 13.6%, and 16.7% in women, respectively. When we used EWGSOP-2 (with Iranian cut-off) criteria, these values were 10.5%, and 12.7% among men and 7.13% and 16.5% in women, respectively. The prevalence sarcopenia and severe sarcopenia by EWGSOP-2 (with European cut-off) were 12.7%, and 13.4% in men and 5.42%, and 13.7% in women, respectively. In both genders, getting older and high-fat mass were positively associated with sarcopenia, and BMI had a significant inverse association in both genders and all defintions.

Conclusions

Results showed that a prevalence of sarcopenia varied largely by using different criteria, in both sexes. EWGSOP2- defined sarcopenia prevalence was lower than that defined using EWGSOP-1 criteria due to different diagnostic factors to detect sarcopenia. Some adverse outcomes should be considered for evaluating sarcopenia to compare the accuracy of EWGSOP-1 and EWGSOP-2.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Cruz-Jentoft A. European Working Group on Sarcopenia in Older People. Sarcopenia: European consensus on definition and diagnosis. Report of the European Workign Group on Sarcopenia in Older People. Age Ageing. 2010;39:412–23.

    Article  Google Scholar 

  2. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(4):601.

    Article  Google Scholar 

  3. Shafiee G, Keshtkar A, Soltani A, Ahadi Z, Larijani B, Heshmat R. Prevalence of sarcopenia in the world: a systematic review and meta- analysis of general population studies. Journal of diabetes metabolic disorders. 2017;16:21.

    Article  Google Scholar 

  4. von Haehling S, Morley JE, Anker SD. An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle. 2010;1(2):129–33.

    Article  Google Scholar 

  5. Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56.

    Article  Google Scholar 

  6. Chen L-K, Liu L-K, Woo J, Assantachai P, Auyeung T-W, Bahyah KS, et al. Sarcopenia in Asia: consensus report of the Asian Working Group for Sarcopenia. J Am Med Dir Assoc. 2014;15(2):95–101.

    Article  Google Scholar 

  7. Shafiee G, Heshmat R, Ostovar A, Nabipour I, Larijani B. Sarcopenia disease in Iran: an overview. J Diabetes Metab Disord. 2019;18(2):665–74.

    Article  Google Scholar 

  8. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2018;48(1):16–31.

    Article  Google Scholar 

  9. Yang L, Yao X, Shen J, Sun G, Sun Q, Tian X, et al. Comparison of revised EWGSOP criteria and four other diagnostic criteria of sarcopenia in Chinese community-dwelling elderly residents. Exp Gerontol. 2020;130:110798.

    Article  CAS  Google Scholar 

  10. Saeki C, Takano K, Oikawa T, Aoki Y, Kanai T, Takakura K, et al. Comparative assessment of sarcopenia using the JSH, AWGS, and EWGSOP2 criteria and the relationship between sarcopenia, osteoporosis, and osteosarcopenia in patients with liver cirrhosis. BMC Musculoskelet Disord. 2019;20(1):615.

    Article  CAS  Google Scholar 

  11. Reiss J, Iglseder B, Alzner R, Mayr-Pirker B, Pirich C, Kassmann H, et al. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients. Age Ageing. 2019;48(5):719–24.

    Article  CAS  Google Scholar 

  12. Ostovar A, Nabipour I, Larijani B, Heshmat R, Darabi H, Vahdat K, et al. Bushehr Elderly Health (BEH) Programme, phase I (cardiovascular system). BMJ Open. 2015;5(12):e009597.

  13. Shafiee G, Ostovar A, Heshmat R, Darabi H, Sharifi F, Raeisi A, et al. Bushehr Elderly Health (BEH) programme: study protocol and design of musculoskeletal system and cognitive function (stage II). BMJ Open. 2017;7(8):e013606.

  14. Aadahl M, Jorgensen T. Validation of a new self-report instrument for measuring physical activity. Med Sci Sports Exerc. 2003;35(7):1196–202.

  15. Leong DP, Teo KK, Rangarajan S, Lopez-Jaramillo P, Avezum A Jr, Orlandini A, et al. Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study. Lancet. 2015;386(9990):266–73.

    Article  Google Scholar 

  16. Rydwik E, Bergland A, Forsen L, Frandin K. Investigation into the reliability and validity of the measurement of elderly people’s clinical walking speed: a systematic review. Physiother Theory Pract. 2012;28(3):238–56.

    Article  CAS  Google Scholar 

  17. Shafiee G, Ostovar A, Heshmat R, Keshtkar AA, Sharifi F, Shadman Z, et al. Appendicular Skeletal Muscle Mass Reference Values and the Peak Muscle Mass to Identify Sarcopenia among Iranian Healthy Population. Int J Prev Med. 2018;9.

  18. Hill KD, Farrier K, Russell M, Burton E. Dysmobility syndrome: current perspectives. Clin Interv Aging. 2017;12:145–52.

    Article  Google Scholar 

  19. McHugh ML. Interrater reliability: the kappa statistic. Biochem Med. 2012;22(3):276–82.

    Article  Google Scholar 

  20. Hashemi R, Shafiee G, Motlagh AD, Pasalar P, Esmailzadeh A, Siassi F, et al. Sarcopenia and its associated factors in Iranian older individuals: results of SARIR study. Arch Gerontol Geriatr. 2016;66:18–22.

  21. Rijk JM, Roos PR, Deckx L, van den Akker M, Buntinx F. Prognostic value of handgrip strength in people aged 60 years and older: a systematic review and meta-analysis. Geriatr Gerontol Int. 2016;16(1):5–20.

  22. Sayer AA, Syddall HE, Martin HJ, Dennison EM, Roberts HC, Cooper C. Is grip strength associated with health-related quality of life? Findings from the Hertfordshire Cohort Study. Age Ageing. 2006;35(4):409–15.

    Article  Google Scholar 

  23. de Freitas MM, de Oliveira VLP, Grassi T, Valduga K, Miller MEP, Schuchmann RA, et al. Difference in sarcopenia prevalence and associated factors according to 2010 and 2018 European consensus (EWGSOP) in elderly patients with type 2 diabetes mellitus. Exp Gerontol. 2020;132:110835.

    Article  Google Scholar 

  24. Locquet M, Beaudart C, Petermans J, Reginster JY, Bruyere O. EWGSOP2 Versus EWGSOP1: impact on the prevalence of sarcopenia and its major health consequences. J Am Med Dir Assoc. 2019;20(3):384–5.

    Article  Google Scholar 

  25. Phu S, Vogrin S, Zanker J, Bani Hassan E, Al Saedi A, Duque G. Agreement between initial and revised european working group on sarcopenia in older people definitions. J Am Med Dir Assoc. 2019;20(3):382–3 e1.

  26. Lau EM, Lynn HS, Woo JW, Kwok TC, Melton LJ 3rd. Prevalence of and risk factors for sarcopenia in elderly Chinese men and women. J Gerontol Ser A Biol Sci Med Sci. 2005;60(2):213–6.

    Article  Google Scholar 

  27. Shaw SC, Dennison EM, Cooper C. Epidemiology of sarcopenia: determinants throughout the lifecourse. Calcif Tissue Int. 2017;101(3):229–47.

  28. Clark DJ, Patten C, Reid KF, Carabello RJ, Phillips EM, Fielding RA. Impaired voluntary neuromuscular activation limits muscle power in mobility-limited older adults. J Gerontol Ser A Biol Sci Med Sci. 2010;65(5):495–502.

    Article  Google Scholar 

  29. Jackson AS, Stanforth PR, Gagnon J, Rankinen T, Leon AS, Rao DC, et al. The effect of sex, age and race on estimating percentage body fat from body mass index: the heritage family study. Int J Obes Relat Metab Disord. 2002;26(6):789–96.

    Article  CAS  Google Scholar 

  30. Lichtash CT, Cui J, Guo X, Chen YD, Hsueh WA, Rotter JI, et al. Body adiposity index versus body mass index and other anthropometric traits as correlates of cardiometabolic risk factors. PloS One. 2013;8(6):e65954.

  31. Dhillon RJ, Hasni S. Pathogenesis and Management of Sarcopenia. Clin Geriatr Med. 2017;33(1):17–26.

    Article  Google Scholar 

Download references

Acknowledgements

We would like to thank all the personnel of the Bushehr Elderly Health program and all the individuals who took part in the study. Also, the authors thank the “World Congress on Osteoporosis, osteoarthritis, and Musculoskeletal Diseases (WCO-IOF-ESCEO 2018) that the preliminary of this study as a poster abstract has been published in proceeding.

Author information

Authors and Affiliations

  1. Chronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Gita Shafiee, Ramin Heshmat & Fatemeh Khatami

  2. Osteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Afshin Ostovar, Noushin Fahimfar & Safoora Gharibzadeh

  3. Elderly Health Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Seyed Masoud Arzaghi

  4. Research Center for Immunodeficiencies (RCID), Tehran University of Medical Sciences (TUMS), Tehran, Iran

    Sara Hanaei

  5. Universal Scientific Education and Research Network (USERN), Tehran, Iran

    Sara Hanaei

  6. The Persian Gulf Tropical Medicine Research Center, Bushehr University of Medical Sciences, Bushehr, Iran

    Iraj Nabipour

  7. Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran

    Bagher Larijani

Authors
  1. Gita Shafiee
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ramin Heshmat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Afshin Ostovar
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Fatemeh Khatami
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Noushin Fahimfar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Seyed Masoud Arzaghi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Safoora Gharibzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sara Hanaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Iraj Nabipour
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Bagher Larijani
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors read and approved the final paper.

Corresponding authors

Correspondence to Ramin Heshmat or Afshin Ostovar.

Ethics declarations

Conflict of interest

Gita Shafiee, Ramin Heshmat, Afshin Ostovar, Fatemeh Khatami, Noushin Fahimfar, Seyed Masoud Arzaghi, Safoora Gharibzadeh, Sara Hanaei, Iraj Nabipour, Bagher Larijani declare that they have no conflict of interest.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Shafiee, G., Heshmat, R., Ostovar, A. et al. Comparison of EWGSOP-1and EWGSOP-2 diagnostic criteria on prevalence of and risk factors for sarcopenia among Iranian older people: the Bushehr Elderly Health (BEH) program. J Diabetes Metab Disord 19, 727–734 (2020). https://doi.org/10.1007/s40200-020-00553-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40200-020-00553-w

Keywords

Search

Navigation